176ACTIVITIES
8ORGS REPRESENTED
44BILLS
Revolving door — covered positions
Federal positions Stephen held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.
Legislative Director, Rep. Vern Buchanan
Legislative Assistant, Senator Marsha Blackburn
Organizations represented
8Orgs whose LD-2 filings list Stephen as an active lobbyist, sorted by activity volume.
Crossroads Strategies, LLC84 activitiesPharmaceutical Research and Manufacturers of America (PhRMA)40 activitiesSecurities Industry and Financial Markets Association24 activitiesAdvamed:advanced Medical Technology Association15 activitiesSoftware & Information Industry Association4 activitiesExxon Mobil Corporation4 activitiesAmerican Association of Colleges of Osteopathic Medicine3 activitiesCoalition for 1099-K Fairness2 activities
Bills they file on
44S. 89110 mentions
S. 52710 mentions
S. 104010 mentions
S. 104110 mentions
S. 109710 mentions
S. 109510 mentions
S. 109610 mentions
H.R. 149210 mentions
S. 83210 mentions
H.R. 53436 mentions
H.R. 24414 mentions
H.R. 36334 mentions
S. 2784 mentions
S. 8364 mentions
S. 27504 mentions
+ 29 more bills referenced in their activities
Topics in Filings
87Policy topics Stephen files on across all their LD-2 activities.
Drug pricing×20
General education about biomedical research and support for scientific funding×18
FY2027 Departments of Labor×16
Health and Human Services, and Education, and Related Agencies Appropriations×16
Inflation Reduction Act×16
General issues×14
Legislative and regulatory issues×12
Affecting the banking industry×12
Asia, and Europe×12
Discussions regarding international economic policy×12
Japan, the UK, and the European Union×12
340B drug discount program×10
Show all 87 topics (+75 more) ▾
Importation of biopharmaceuticals×10
International pharmaceutical supply chain×10
PBM reform×10
TRICARE Pharmacy Program×10
Pandemic and All-Hazards Preparedness Act×10
Bipartisan Health Care Act×10
Prescription Pricing for the People Act×10
Drug Competition Enhancement Act×10
Affordable Prescriptions for Patients Act×10
Interagency Patent Coordination and Improvement Act×10
Stop STALLING Act×10
Preserve Access to Affordable Generics and Biosimilars Act×10
Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients×10
FY2027 Agriculture×10
Rural Development×10
Food and Drug Administration, and Related Agencies Appropriations×10
Medicare Part B reimbursement×10
CMMI Drug Pricing Demonstration Programs×10
Valued-Based Payments×10
EPIC Act×10
Biopharmaceutical innovation and patent policy×10
Bayh-Dole march-in rights policy×10
Section 232 tariff investigation on branded pharmaceuticals×10
One Big Beautiful Bill Act×8
Children and Teens Online Privacy Protection Act×8
FY2027 National Defense Authorization Act×7
Farm Bill Reauthorization×6
Reimbursement issues×6
Advocacy on tax issues×6
General education to advance policies×6
Federal policy×4
Federal Reserve, and Department of the Treasury×4
Sanctions affecting financial institutions×4
Improving Disclosure for Investors Act×4
Digital asset market structure issues×4
Digital Asset Market Clarity Act×4
Tax policy×4
Impacting investment banks and investment products×4
Incentives to encourage retirement savings×4
Municipal bond issues×4
Corporate and international tax issues×4
Kids Off Social Media Act×4
SANDBOX Act×4
Kids Online Safety Act×4
RESET Act×4
Sammys Law×4
App Store Accountability Act×4
Shielding Children's Retinas from Egregious Exposure on the Net×4
Safe Social Media Act×4
Algorithmic Choice and Transparency Act×4
No Fentanyl on Social Media Act×4
SAFE BOTs Act×4
Kids Internet Safety Partnership Act×4
AI Warnings And Resources for Education×4
Safer Guarding of Adolescents from Malicious Interactions on Network Games×4
Assessing Safety Tools for Parents and Minors Act×4
Stop Profiling Youth and×4
Safe Messaging for Kids Act×4
Dont Sell Kids Data Act×4
Parents Over Platforms Act×4
Remote Access Security Act×4
Discussions regarding implementation×3
Impacting third party repair of medtech×3
Medicare-funded Graduate Medical Education×3
Osteopathic Funding and Representation×3
FAIR Act×3
Community TEAMS Act×3
Discussions related to clean energy, carbon capture and storage×2
Infrastructure Investment and Jobs Act×2
Discussions related to the EU CSDDD Proposal×2
Hydrogen tax credit issues×2
Legislative issues×2
Saving Gig Economy Taxpayers Act×2
SNOOP Act×2
Red Tape Reduction Act×2
Issue mix
LDA general-issue codes weighted by activity count.
Trade (domestic/foreign)23
Medicare/Medicaid19
Health Issues16
Taxation/Internal Revenue Code14
Pharmacy12
Financial Institutions/Investments/Securities10
Banking10
Copyright/Patent/Trademark10
Budget/Appropriations9
Medical/Disease Research/Clinical Labs6